Impact of bias in serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A multiples of the median levels on first-trimester screening for trisomy 21

Ultrasound in Obstetrics and Gynecology

Volumn 38, Issue 3, 2011, Pages 309-313

  Wright, D ^a   Abele, H ^b   Baker, A ^b   Kagan, K O ^b  

^a UNIVERSITY OF PLYMOUTH   (United Kingdom)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

first trimester screening; free hCG; nuchal translucency; PAPP A; trisomy 21

Indexed keywords

BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; DENMARK; DOWN SYNDROME; EPIDEMIOLOGY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MATERNAL AGE; METABOLISM; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE; PREGNANCY; RECEIVER OPERATING CHARACTERISTIC; UNITED KINGDOM;

BIAS (EPIDEMIOLOGY); BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DENMARK; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; GREAT BRITAIN; HUMANS; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; ROC CURVE;

EID: 80052295754     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.8987     Document Type: Article

References (17)

1. Kagan KO, Wright D, Baker A, Sahota D, Nicolaides KH,. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 2008; 31: 618-624.
2. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O,. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage firsttrimester screening. Ultrasound Obstet Gynecol 2005; 25: 221-226. (Pubitemid 40432687)
3. Wright D, Kagan KO, Molina FS, Gazzoni A, Nicolaides KH,. A mixture model of nuchal translucency thickness in screening for chromosomal defects. Ultrasound Obstet Gynecol 2008; 31: 376-383.
4. Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH,. Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 2009; 34: 14-18.
5. Wright D, Spencer K, Kagan K, Tørring N, Petersen OB, Christou A, Kallikas J, Nicolaides KH,. First-trimester combined screening for trisomy 21 at 7-14 weeks' gestation. Ultrasound Obstet Gynecol 2010; 36: 404-411.
6. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH,. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 2008; 31: 493-502.
7. Snijders RJ, Thom EA, Zachary JM, Platt LD, Greene N, Jackson LG, Sabbagha RE, Filkins K, Silver RK, Hogge WA, Ginsberg NA, Beverly S, Morgan P, Blum K, Chilis P, Hill LM, Hecker J, Wapner RJ,. First-trimester trisomy screening: nuchal translucency measurement training and quality assurance to correct and unify technique. Ultrasound Obstet Gynecol 2002; 19: 353-359. (Pubitemid 34592131)
8. Kagan KO, Wright D, Etchegaray A, Zhou Y, Nicolaides KH,. Effect of deviation of nuchal translucency measurements on the performance of screening for trisomy 21. Ultrasound Obstet Gynecol 2009; 33: 657-664.
9. Nix B, Wright D, Baker A,. The impact of bias in MoM values on patient risk and screening performance for Down syndrome. Prenat Diagn 2007; 27: 840-845. (Pubitemid 47425403)
10. The National Screening Committee. Down's syndrome screening quality assurance support service QA of the MoM letter. [Accessed 20 January 2011].
11. Office for National Statistics. Birth Statistics. Review of the Registrar General on births and patterns of family building in England and Wales. 2000-2002. Series FM1, No. 29-31. The Stationery Office: London.
12. Cuckle HS, Wald NJ, Thompson SG,. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987; 94: 387-402. (Pubitemid 17068086)
13. Snijders R,. Fetal loss in Down syndrome pregnancies. Prenat Diagn 1999; 19: 1180.
14. The National Screening Committee. Down's syndrome screening model of best practice consultation. [Accessed 20 January 2011].
15. Ekelund CK, Jorgensen FS, Petersen OB, Sundberg K, Tabor A,. Impact of a new national screening policy for Down's syndrome in Denmark: population based cohort study. BMJ 2008; 337: a2547.
16. Salomon LJ, Bernard M, Amarsy R, Bernard JP, Ville Y,. The impact of crown-rump length measurement error on combined Down syndrome screening: a simulation study. Ultrasound Obstet Gynecol 2009; 33: 506-511.
17. Cruz J, Cruz G, Minekawa R, Maiz N, Nicolaides KH,. Effect of temperature on free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A concentration. Ultrasound Obstet Gynecol 2010; 36: 141-146.